‘Lipiodol’ takes drug price negotiation after being designated as shortage-prevented drug
‘Lipiodol’ which has recently caused controversy with its supply suspension will get on a drug price negotiation after being designated as a shortage-prevented drug.
‘Erbitux’ which ended the drug price negotiation with the National Health Insurance Service(NHIS) will be applied with the risk-sh...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
